Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

被引：101
|
作者：
Rosenstock, J. [1 ,2 ]
Fonseca, V. [3 ]
McGill, J. B. [4 ]
Riddle, M. [5 ]
Halle, J. P. [6 ]
Hramiak, I. [7 ]
Johnston, P. [8 ]
Davis, M. [9 ]
机构：
[1] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX 75230 USA
[2] Univ Texas Southwestern Med Sch, Dallas, TX USA
[3] Tulane Univ, Med Ctr, New Orleans, LA USA
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ Montreal, Montreal, PQ, Canada
[7] Univ Western Ontario, London, ON, Canada
[8] Sanofi Aventis, Bridgewater, NJ USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
来源：
DIABETOLOGIA | 2009年 / 52卷 / 09期
关键词：
Cancer; Insulin analogues; Insulin glargine; Insulin therapy; Malignancy; NPH insulin; Type; 2; diabetes;
D O I：
10.1007/s00125-009-1452-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1971 / 1973
页数：3
相关论文
共 50 条
  • [1] Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
    J. Rosenstock
    V. Fonseca
    J. B. McGill
    M. Riddle
    J. P. Hallé
    I. Hramiak
    P. Johnston
    M. Davis
    [J]. Diabetologia, 2009, 52 : 1971 - 1973
  • [2] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
    Rosenstock, J.
    Fonseca, V.
    McGill, J. B.
    Riddle, M.
    Halle, J. -P.
    Hramiak, I.
    Johnston, P.
    Davis, M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1778 - 1788
  • [3] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
    J. Rosenstock
    V. Fonseca
    J. B. McGill
    M. Riddle
    J.-P. Hallé
    I. Hramiak
    P. Johnston
    M. Davis
    [J]. Diabetologia, 2009, 52 : 1778 - 1788
  • [4] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]
    Rosenstock, J.
    Fonseca, V.
    McGill, J. B.
    Riddle, M.
    Halle, J. -P.
    Hramiak, I.
    Johnston, P.
    Davis, M.
    [J]. DIABETOLOGIA, 2009, 52 (10) : 2236 - 2239
  • [5] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]
    J. Rosenstock
    V. Fonseca
    J. B. McGill
    M. Riddle
    J.-P. Hallé
    I. Hramiak
    P. Johnston
    M. Davis
    [J]. Diabetologia, 2009, 52 : 2236 - 2239
  • [6] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
    Min Liu
    Zhiguang Zhou
    Jinhua Yan
    Pin Li
    Wenhui Song
    Junfen Fu
    Xiaobo Chen
    Weigang Zhao
    Li Xi
    Xiaoping Luo
    Liang Sha
    Xueyuan Deng
    Chunxiu Gong
    [J]. BMC Endocrine Disorders, 16
  • [7] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
    Liu, Min
    Zhou, Zhiguang
    Yan, Jinhua
    Li, Pin
    Song, Wenhui
    Fu, Junfen
    Chen, Xiaobo
    Zhao, Weigang
    Xi, Li
    Luo, Xiaoping
    Sha, Liang
    Deng, Xueyuan
    Gong, Chunxiu
    [J]. BMC ENDOCRINE DISORDERS, 2016, 16 : 67
  • [8] Transfer of patients with type 1 diabetes from NPH insulin to insulin glargine as basal insulin: a multicentre, randomised, parallel-group, open-label study
    Bolli, G.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    [J]. DIABETOLOGIA, 2006, 49 : 607 - 607
  • [9] Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine Hagedorn insulin in patients with type 2 diabetes
    Linn, Thomas
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemens
    Bretzel, Reinhard G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3839 - 3846
  • [10] Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
    Fritsche, A
    Schweitzer, MA
    Häring, HU
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (12) : 952 - 959
12345